The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease

OBJECTIVE Antithyroidal drugs (ATD) are used in the management of Graves' disease either as primary therapy for several months while awaiting remission of the disease or as pretreatment for several weeks prior to definitive radioactive iodine therapy (RAI). We have reported previously that pret...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical endocrinology (Oxford) Vol. 47; no. 4; pp. 425 - 430
Main Authors:	Hancock, Lloyd D., Tuttle, R. Michael, LeMar, Homer, Bauman, John, Patience, Troy
Format:	Journal Article
Language:	English
Published:	Oxford, UK Blackwell Science Ltd 01-10-1997 Blackwell
Subjects:	Adult Antithyroid Agents - therapeutic use Biological and medical sciences Chi-Square Distribution Combined Modality Therapy Endocrinopathies Female Graves Disease - drug therapy Graves Disease - radiotherapy Humans Iodine Radioisotopes - therapeutic use Male Medical sciences Non tumoral diseases. Target tissue resistance. Benign neoplasms Propylthiouracil - therapeutic use Retrospective Studies Statistics, Nonparametric Thyroid. Thyroid axis (diseases) Time Factors Treatment Failure Endocrinopathy Human Biological properties Immunopathology Radioprotector Hyperthyroidism Thyroid diseases Autoimmune disease Propylthiouracil Radioisotope Thioureas Association Treatment Graves disease Biological effect Iodine
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!